What is Usana Health Sciences Inc. share price today?

Usana Health Sciences Inc. (USNA) share price today is {{live_price}}.

Can Indians buy Usana Health Sciences Inc. shares?

Yes, Indians can invest in the Usana Health Sciences Inc. (USNA) from India. With INDmoney, you can buy Usana Health Sciences Inc. at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Usana Health Sciences Inc. at zero transaction cost.

How can I buy Usana Health Sciences Inc. shares from India?

It is very easy to buy Usana Health Sciences Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Usana Health Sciences Inc. be purchased?

Yes, you can buy fractional shares of Usana Health Sciences Inc. with INDmoney app.

What are the documents required to start investing in Usana Health Sciences Inc. stocks?

To start investing in Usana Health Sciences Inc., You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Usana Health Sciences Inc.

Today’s highest price of Usana Health Sciences Inc. (USNA) is {{1_rba_end}}. Today’s lowest price of Usana Health Sciences Inc. (USNA) is {{1_rba_st}}.

What is today's market capitalisation of Usana Health Sciences Inc.

Today's market capitalisation of Usana Health Sciences Inc. USNA is 690.3M

What is the 52 Week High and Low Range of Usana Health Sciences Inc.

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Usana Health Sciences Inc. is down from its 52 Week High?

Usana Health Sciences Inc. (USNA) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Usana Health Sciences Inc. is up from its 52 Week low?

Usana Health Sciences Inc. (USNA) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Usana Health Sciences Inc.?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Usana Health Sciences Inc.

Mr. Kevin G. Guest is the current Chief Executive Officer (CEO) of Usana Health Sciences Inc..

Home>
US Stocks>
Usana Health Sciences Inc.

Usana Health Sciences Inc. (USNA)

$35.17

-0.68

(-1.9%)▲

Live

Performance

$34.80
$35.76
$35.17
1.05%
Downside
Day's Volatility :2.68%
Upside
1.65%
$34.76
$57.12
$35.17
1.17%
Downside
52 Weeks Volatility :39.15%
Upside
38.43%

Returns

Period	Usana Health Sciences Inc.	Sector (Consumer Staples)	Index (Russel 2000)
3 Months	-22.4%	5.3%	0.0%
6 Months	-18.95%	10.5%	0.0%
1 Year	-34.29%	22.3%	0.0%
3 Years	-64.26%	16.3%	-23.0%

Highlights

Market Capitalization	690.3M
Book Value	$26.89
Earnings Per Share (EPS)	2.86
PE Ratio	12.67
PEG Ratio	1.0
Wall Street Target Price	48.0

Profit Margin	6.29%
Operating Margin TTM	8.38%

Return On Assets TTM	8.54%
Return On Equity TTM	11.23%

Revenue TTM	875.1M
Revenue Per Share TTM	45.67
Quarterly Revenue Growth YOY	-10.6%
Gross Profit TTM	804.7M
EBITDA	97.5M
Diluted Eps TTM	2.86
Quarterly Earnings Growth YOY	-0.39

EPS Estimate Current Year	2.49
EPS Estimate Next Year	2.71
EPS Estimate Current Quarter	0.65
EPS Estimate Next Quarter	0.56

Analyst Recommendation

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Usana Health Sciences Inc.(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 36.48%

Current $35.17

Target $48.00

Company Financials

	FY18	Y/Y Change
Revenue	1.2B	↑ 13.56%
Net Income	126.2M	↑ 101.85%
Net Profit Margin	10.61%	↑ 4.64%

	FY19	Y/Y Change
Revenue	1.1B	↓ 10.79%
Net Income	100.5M	↓ 20.36%
Net Profit Margin	9.48%	↓ 1.13%

	FY20	Y/Y Change
Revenue	1.1B	↑ 6.95%
Net Income	124.7M	↑ 24.01%
Net Profit Margin	10.99%	↑ 1.51%

	FY21	Y/Y Change
Revenue	1.2B	↑ 4.57%
Net Income	116.5M	↓ 6.54%
Net Profit Margin	9.82%	↓ 1.17%

	FY22	Y/Y Change
Revenue	998.6M	↓ 15.83%
Net Income	69.4M	↓ 40.47%
Net Profit Margin	6.94%	↓ 2.88%

	FY23	Y/Y Change
Revenue	921.0M	↓ 7.77%
Net Income	63.8M	↓ 8.02%
Net Profit Margin	6.93%	↓ 0.01%

	Q1 FY23	Q/Q Change
Revenue	248.4M	↑ 8.95%
Net Income	18.4M	↑ 43.67%
Net Profit Margin	7.4%	↑ 1.79%

	Q2 FY23	Q/Q Change
Revenue	238.2M	↓ 4.09%
Net Income	17.3M	↓ 5.93%
Net Profit Margin	7.26%	↓ 0.14%

	Q3 FY23	Q/Q Change
Revenue	213.4M	↓ 10.43%
Net Income	11.3M	↓ 34.38%
Net Profit Margin	5.32%	↓ 1.94%

	Q4 FY23	Q/Q Change
Revenue	221.1M	↑ 3.62%
Net Income	16.8M	↑ 47.76%
Net Profit Margin	7.58%	↑ 2.26%

	Q1 FY24	Q/Q Change
Revenue	227.8M	↑ 3.04%
Net Income	16.5M	↓ 1.37%
Net Profit Margin	7.26%	↓ 0.32%

	Q2 FY24	Q/Q Change
Revenue	212.9M	↓ 6.55%
Net Income	10.4M	↓ 36.92%
Net Profit Margin	4.9%	↓ 2.36%

	FY18	Y/Y Change
Total Assets	554.5M	↑ 6.78%
Total Liabilities	163.3M	↑ 4.65%

	FY19	Y/Y Change
Total Assets	516.9M	↓ 6.77%
Total Liabilities	165.2M	↑ 1.17%

	FY20	Y/Y Change
Total Assets	640.9M	↑ 23.98%
Total Liabilities	199.2M	↑ 20.59%

	FY21	Y/Y Change
Total Assets	577.7M	↓ 9.85%
Total Liabilities	182.6M	↓ 8.34%

	FY22	Y/Y Change
Total Assets	596.5M	↑ 3.26%
Total Liabilities	162.1M	↓ 11.25%

	FY23	Y/Y Change
Total Assets	632.8M	↑ 6.07%
Total Liabilities	135.6M	↓ 16.36%

	Q1 FY23	Q/Q Change
Total Assets	605.5M	↑ 1.51%
Total Liabilities	150.2M	↓ 7.34%

	Q2 FY23	Q/Q Change
Total Assets	602.7M	↓ 0.47%
Total Liabilities	133.9M	↓ 10.87%

	Q3 FY23	Q/Q Change
Total Assets	601.1M	↓ 0.25%
Total Liabilities	130.8M	↓ 2.32%

	Q4 FY23	Q/Q Change
Total Assets	632.8M	↑ 5.26%
Total Liabilities	135.6M	↑ 3.67%

	Q1 FY24	Q/Q Change
Total Assets	629.3M	↓ 0.55%
Total Liabilities	129.3M	↓ 4.62%

	Q2 FY24	Q/Q Change
Total Assets	631.4M	↑ 0.34%
Total Liabilities	119.2M	↓ 7.79%

	FY18	Y/Y Change
Operating Cash Flow	152.1M	↑ 22.89%
Investing Cash Flow	-69.0M	↑ 434.82%
Financing Cash Flow	-105.3M	↑ 109.23%

	FY19	Y/Y Change
Operating Cash Flow	126.7M	↓ 16.69%
Investing Cash Flow	47.5M	↓ 168.83%
Financing Cash Flow	-152.1M	↑ 44.43%

	FY20	Y/Y Change
Operating Cash Flow	160.4M	↑ 26.57%
Investing Cash Flow	-34.0M	↓ 171.51%
Financing Cash Flow	-59.4M	↓ 60.91%

	FY21	Y/Y Change
Operating Cash Flow	121.2M	↓ 24.42%
Investing Cash Flow	-14.2M	↓ 58.23%
Financing Cash Flow	-181.4M	↑ 205.19%

	FY22	Y/Y Change
Operating Cash Flow	103.9M	↓ 14.29%
Investing Cash Flow	-12.4M	↓ 12.81%
Financing Cash Flow	-30.1M	↓ 83.41%

	Q1 FY23	Q/Q Change
Operating Cash Flow	12.8M	↓ 68.28%
Investing Cash Flow	-3.4M	↑ 2.93%
Financing Cash Flow	-3.2M	↑ 2032.67%

	Q2 FY23	Q/Q Change
Operating Cash Flow	9.6M	↓ 25.57%
Investing Cash Flow	179.0K	↓ 105.3%
Financing Cash Flow	-55.0K	↓ 98.28%

	Q3 FY23	Q/Q Change
Operating Cash Flow	22.2M	↑ 132.79%
Investing Cash Flow	-1.5M	↓ 912.29%
Financing Cash Flow	-11.6M	↑ 21065.45%

Technicals Summary

Sell

Neutral

Buy

Usana Health Sciences Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Usana Health Sciences Inc.	-5.86%	-18.95%	-34.29%	-64.26%	-48.71%
Kraft Heinz Company, The	3.81%	-5.64%	15.68%	-1.04%	29.45%
Mccormick & Company, Incorporated	-3.62%	7.35%	31.79%	-0.16%	-1.24%
Hormel Foods Corporation	2.26%	-8.39%	3.97%	-22.73%	-20.79%
General Mills, Inc.	-5.74%	-1.74%	10.6%	11.91%	33.17%
Kellanova	0.53%	39.79%	64.17%	31.4%	29.68%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Usana Health Sciences Inc.	12.67	12.67	1.0	2.49	0.11	0.09	NA	26.89
Kraft Heinz Company, The	23.04	23.04	0.93	3.02	0.04	0.04	0.04	40.44
Mccormick & Company, Incorporated	27.27	27.27	2.64	2.93	0.15	0.05	0.02	20.2
Hormel Foods Corporation	22.51	22.51	2.66	1.58	0.1	0.05	0.04	14.35
General Mills, Inc.	16.65	16.65	3.62	4.5	0.24	0.07	0.03	16.69
Kellanova	32.28	32.28	1.64	3.7	0.23	0.06	0.03	9.66

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Usana Health Sciences Inc.	Sell	$690.3M	-48.71%	12.67	6.29%
Kraft Heinz Company, The	Buy	$43.6B	29.45%	23.04	7.3%
Mccormick & Company, Incorporated	Hold	$21.5B	-1.24%	27.27	11.87%
Hormel Foods Corporation	Hold	$17.7B	-20.79%	22.51	6.52%
General Mills, Inc.	Hold	$38.8B	33.17%	16.65	12.14%
Kellanova	Hold	$27.9B	29.68%	32.28	7.07%

Insights on Usana Health Sciences Inc.

Decreasing Revenue
Revenue is down for the last 2 quarters, 227.8M → 212.86M (in $), with an average decrease of 6.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 16.76M → 10.43M (in $), with an average decrease of 19.1% per quarter
Vs K
In the last 1 year, Kellanova has given 61.7% return, outperforming this stock by 97.5%
Vs K
In the last 3 years, Kellanova has given 31.4% return, outperforming this stock by 95.7%

Institutional Holdings

BlackRock Inc
9.29%
Vanguard Group Inc
8.27%
Renaissance Technologies Corp
6.19%
Pzena Investment Management, LLC
5.13%
Dimensional Fund Advisors, Inc.
3.59%
Pacer Advisors, INC.
2.45%

Organization	Usana Health Sciences Inc.
Employees	1800
CEO	Mr. Kevin G. Guest
Industry	Consumer Non-Durables

Usana Health Sciences Inc. (USNA)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Decreasing Revenue

Decreasing Net Profit

Vs K

Vs K

Institutional Holdings

Company Information

Discover More

FAQs